Article

| CRISPR Medicine | This is an overview of all our articles

Prime editing corrects G6PD deficiency in stem...

Aug. 19, 2025

A plasmid-delivered prime editing strategy corrected the glucose-6-phosphate dehydrogenase (G6PD) Viangchan (c.871G>A) mutation in engineered HEK293T...

CMN Weekly (15 August 2025) - Your Weekly CRISPR...

CMN Weekly

Aug. 15, 2025

Some of the best links we picked up around the internet

Recent Clinical Trial Updates from CRISPR Medicine...

Aug. 13, 2025

The latest clinical update includes dosing announcements for two trials, with the first patients now treated with Epicrispr Biotechnologies’ EPI-321...

CMN Weekly (8 August 2025) - Your Weekly CRISPR...

CMN Weekly

Aug. 8, 2025

Some of the best links we picked up around the internet

New Partnership Announcement: CMN x EDUGENE

Aug. 5, 2025

We’re excited to announce a strategic partnership between CRISPR Medicine News (CMN) and EDUGENE - coming together to advance CRISPR and biotechnology...

CRISPR-Edited Beta Cells Avoid Immune Rejection...

CMN Briefs

Aug. 5, 2025

CRISPR-Cas12b technology was used to edit allogeneic donor islet cells for transplantation into a man with long-standing type 1 diabetes....

CMN Weekly (1 August 2025) - Your Weekly CRISPR...

CMN Weekly

Aug. 1, 2025

Some of the best links we picked up around the internet

YOLT-203 Awarded EMA Orphan Drug Designation for...

Jul. 30, 2025

YolTech Therapeutics announced earlier this week that the European Medicines Agency has granted Orphan Drug Designation to YOLT-203, its...